SO
PCRX icon

STRS Ohio’s Pacira BioSciences PCRX Stock Holding History

STRS Ohio’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,100
Closed -$106K – 2242
2025
Q3 		$106K Hold
4,100
– – ﹤0.01% 1820
2025
Q2 		$98K Buy
4,100
+1,100
+37% +$27.7K ﹤0.01% 1869
2025
Q1 		$74.5K Hold
3,000
– – ﹤0.01% 1720
2024
Q4 		$56.5K Buy
3,000
+2,100
+233% +$36.9K ﹤0.01% 1716
2024
Q3 		$13.5K Buy
+900
New +$15.4K ﹤0.01% 1917
2023
Q1 		– Sell
-200
Closed -$7K – 2028
2022
Q4 		$7K Hold
200
– – ﹤0.01% 1937
2022
Q3 		$10K Sell
200
-500
-71% -$27.8K ﹤0.01% 1964
2022
Q2 		$40K Sell
700
-1,000
-59% -$65.5K ﹤0.01% 1890
2022
Q1 		$129K Buy
+1,700
New +$113K ﹤0.01% 1797
2021
Q2 		– Sell
-300
Closed -$21K – 2371
2021
Q1 		$21K Hold
300
– – ﹤0.01% 2105
2020
Q4 		$17K Sell
300
-2,000
-87% -$117K ﹤0.01% 2084
2020
Q3 		$138K Buy
2,300
+1,600
+229% +$93K ﹤0.01% 1759
2020
Q2 		$36K Buy
+700
New +$29.3K ﹤0.01% 1959
2016
Q3 		– Sell
-160,000
Closed -$5.4M – 1944
2016
Q2 		$5.4M Sell
160,000
-41,300
-21% -$2.03M 0.02% 466
2016
Q1 		$10.7M Buy
201,300
+97,200
+93% +$5.69M 0.05% 365
2015
Q4 		$7.99M Buy
104,100
+103,700
+25,925% +$5.87M 0.04% 405
2015
Q3 		$16K Sell
400
-2,900
-88% -$178K ﹤0.01% 1836
2015
Q2 		$233K Sell
3,300
-2,200
-40% -$173K ﹤0.01% 1529
2015
Q1 		$488K Sell
5,500
-500
-8% -$50.7K ﹤0.01% 1213
2014
Q4 		$532K Sell
6,000
-400
-6% -$37.8K ﹤0.01% 1189
2014
Q3 		$620K Buy
6,400
+900
+16% +$87.6K ﹤0.01% 1074
2014
Q2 		$505K Buy
5,500
+5,100
+1,275% +$388K ﹤0.01% 1224
2014
Q1 		$28K Buy
+400
New +$27.2K ﹤0.01% 1658

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

STRS Ohio's PCRX Position: Q4 2025 in Review

STRS Ohio sold out of Pacira BioSciences (PCRX) in Q4 2025, closing a stake of 4,100 shares — an estimated $106K sold.

STRS Ohio first reported a position in PCRX in Q1 2014 and held it in 23 quarters. The position peaked at $10.7M in Q1 2016. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2025.

  • STRS Ohio reported no remaining Pacira BioSciences position as of Q4 2025 after selling out during the quarter.
  • STRS Ohio sold 4,100 Pacira BioSciences shares in Q4 2025, an estimated $106K.
  • STRS Ohio first reported a position in Pacira BioSciences in Q1 2014 and held it in 23 quarters.
  • STRS Ohio's Pacira BioSciences position peaked at $10.7M in Q1 2016.
  • 260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2025.

Based on STRS Ohio's 13F filing for Q4 2025, filed 2 Feb 2026.